News Sentiment

CSTL sentiment intelligence

Castle Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 39 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 24.16 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.9% over one week, +14.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Castle Biosciences CEO Maetzold sells $95,622 in company stock By Investing.com

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 1.9% Price digesting
Trend fit Trend inactive 14.4% over four weeks
Fair value 0.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 21
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Market source 7
TradingView 4
Investing.com Nigeria 3
Investing.com 3
PR Newswire 3
GuruFocus 2
Stock Traders Daily 2

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 8
Analyst action 4
Regulatory and legal 3
Macro sensitivity 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-39 of 39